Chronic Active Liver Disease: Classification and Treatment

1973 ◽  
Vol 53 (1) ◽  
pp. 88-94 ◽  
Author(s):  
Roger D. Soloway ◽  
W. H. J. Summerskill
1968 ◽  
Vol 55 (6) ◽  
pp. 724-729 ◽  
Author(s):  
Leslie J. Schoenfield ◽  
W.H.J. Summerskill ◽  
Michael G. Geall

1977 ◽  
Vol 72 (5) ◽  
pp. 910-913 ◽  
Author(s):  
S.W. Schalm ◽  
W.H.J. Summerskill ◽  
V.L.W. Go

1979 ◽  
Vol 4 (1) ◽  
pp. 43-50 ◽  
Author(s):  
Antonio Ponzetto ◽  
Mario Zucca ◽  
Fabrizio Marcucci ◽  
Mario Rizzetto ◽  
Giovanni C. Actis ◽  
...  

The Lancet ◽  
1971 ◽  
Vol 298 (7722) ◽  
pp. 484-485 ◽  
Author(s):  
Møgens Bjørneboe

1977 ◽  
Author(s):  
S. Coccheri ◽  
G. Palareti ◽  
M. Poggi ◽  
G. Oca

Positivity of paracoagulation tests in a previously studied group of 80 patients with chronic active liver disease did not exceed 5-10% of the cases. In the present study, plasma samples from 20 cases of decompensated liver cirrhosis, assessed by liver biopsy, were investigated by means of agarose cromatography. Fibrinogen related materials were measured immunologically and by Staphylococcal Clumping Test.First appearance of fibrinogen-like materials occurred at earlier fractions in cirrhotic patients in comparison with normal controls. The relative amount of soluble fibrin monomer complexes (SFMC) as referred to total fibrinogen was significantly increased. No correlation was found between the amount of SFMC and the severity of fibrinogen polymerisation defect.Circulating SFMC are therefore present in severe liver cirrhosis. However, DIC may not be the only proposed explanation for this finding.


1978 ◽  
Vol 74 (5) ◽  
pp. 883-889 ◽  
Author(s):  
A.J.M. Vogten ◽  
N. Hadzic ◽  
R.G. Shorter ◽  
W.H.J. Summerskill ◽  
W.F. Taylor

Sign in / Sign up

Export Citation Format

Share Document